In Vivo and In Vitro Protective Effects of Pentamethylquercetin on Cardiac Hypertrophy

被引：0
|
作者：
Ting He
Lei Chen
Yong Chen
Yi Han
Wei-Qin Yang
Man-Wen Jin
机构：
[1] Huazhong University of Science and Technology,Department of Pharmacology, Tongji Medical College
[2] Wuhan University of Science and Technology,Department of neurosurgery, TianYou Hospital
来源：
Cardiovascular Drugs and Therapy | 2012年 / 26卷
关键词：
Pentamethylquercetin; Pressure overload; Cardiac hypertrophy; Cardiac fibrosis; Inflammation; PPAR α and PPAR β;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 120
页数：11
相关论文
共 50 条
  • [1] In Vivo and In Vitro Protective Effects of Pentamethylquercetin on Cardiac Hypertrophy
    He, Ting
    Chen, Lei
    Chen, Yong
    Han, Yi
    Yang, Wei-Qin
    Jin, Man-Wen
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (02) : 109 - 120
  • [2] Effects of DNA methylation inhibition in pathological cardiac hypertrophy in vitro and in vivo
    Loeser, A.
    Stenzig, J.
    Schneeberger, Y.
    Hirt, M. N.
    Hansen, A.
    Foo, R. S. -Y.
    Eschenhagen, T.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 109 : 25 - 25
  • [3] Calcineurin regulates cardiac hypertrophy in vitro and in vivo
    Taigen, T
    De Windt, LJ
    Lim, HW
    Molkentin, JD
    [J]. FASEB JOURNAL, 2000, 14 (04): : A696 - A696
  • [4] Protective role of Urotensin II signaling on cardiac hypertrophy in vivo
    Esposito, G.
    Borgia, F.
    Guerriero, R.
    Capasso, E.
    De Angelis, M. C.
    Sorda, G.
    Petretta, M. P.
    Perrino, C.
    Rapacciuolo, A.
    Chiariello, M.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 364 - 364
  • [5] Genistein attenuates pathological cardiac hypertrophy in vivo and in vitro
    Meng, Y.
    Zhang, Y.
    Ma, Z.
    Zhou, H.
    Ni, J.
    Liao, H.
    Tang, Q.
    [J]. HERZ, 2019, 44 (03) : 247 - 256
  • [6] Sibjotang Protects against Cardiac Hypertrophy In Vitro and In Vivo
    Son, Chan-Ok
    Hong, Mi-Hyeon
    Kim, Hye-Yoom
    Han, Byung-Hyuk
    Seo, Chang-Seob
    Lee, Ho-Sub
    Yoon, Jung-Joo
    Kang, Dae-Gill
    [J]. LIFE-BASEL, 2023, 13 (12):
  • [7] Biochanin A inhibits cardiac hypertrophy and fibrosis in vivo and in vitro
    Feng, Zhenyu
    Zhang, Ningning
    Bai, Jie
    Lin, Qiu-yue
    Xie, Yunpeng
    Xia, Yun-long
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [8] Stimulation of PPARγ inhibits cardiac hypertrophy in vitro and in vivo.
    Asakawa, M
    Takano, H
    Nagai, T
    Saito, T
    Masuda, Y
    Uozumi, H
    Komuro, I
    [J]. CIRCULATION, 2000, 102 (18) : 72 - 72
  • [9] CHARACTERISATION OF IN VIVO AND IN VITRO MODELS FOR EPIGENOMIC INVESTIGATIONS OF CARDIAC HYPERTROPHY
    Fernandez-Aroca, Diego
    Frost, Stephanie
    Tikkas, Georgios
    Rodriguez, Adrian
    Tinker, Andrew
    Villar, Diego
    [J]. HEART, 2023, 109 : A297 - A297
  • [10] Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro
    Zhang, Ningning
    An, Xiangbo
    Lang, Pingping
    Wang, Feng
    Xie, Yunpeng
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 1016 - 1023
12345